BioSpace News Archive

Bio-Techne Corporation Bio-Techne announced the launch of a new medium for the expansion and maintenance of induced pluripotent stem cells for use in both research and translational workflows.

ReForm Biologics , Inc., today announced the appointment of Neal Muni, MD, MSPH, as Executive Vice President and Chief Operating Officer.

Dante Labs today announced the appointments of Andre Nel, Dalila Rahmani, Laura D’Angelo and Omar Elbakshish to the company’s management team, expanding its global leadership to help scale the growing business.

Neogene Therapeutics, Inc. today announced the appointment of Han Lee, Ph.D., MBA, as its Chief Financial Officer.

Phase I/II investigator-Initiated Trial to be conducted at Weill Cornell Medicine, led by Principal Investigator, Dr. Scott T. Tagawa

Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert Xpress CoV-2/Flu/RSV plus

Nuvectis Pharma, Inc., a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, announced today that it has licensed exclusive worldwide rights to develop and commercialize a novel, oral, small molecule, SRC/YES1 inhibitor from the University of Edinburgh in Scotland.

Pyxis Oncology announced the appointment of Jay M. Feingold, M.D., Ph.D., as Chief Medical Officer.

Werewolf Therapeutics, Inc. (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer, today announced that members of its leadership team will present at the Next-Gen Cytokine Therapeutics Summit on September 22.

Kronos Bio, Inc., a company dedicated to transforming the lives of those affected by cancer, announced the appointment of Marni Kottle as senior vice president of Corporate Communications and Investor Relations.